Sopharma Trading AD (BUL:SFT)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 2.860
-0.020 (-0.69%)
At close: Jul 10, 2026
Sopharma Trading AD Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,313 | 2,280 | 1,942 | 1,673 | 1,479 | 1,336 |
Other Revenue | 14.81 | 13.54 | 9.41 | 5.06 | 4.26 | - |
| 2,328 | 2,294 | 1,951 | 1,678 | 1,483 | 1,336 | |
Revenue Growth (YoY) | 13.68% | 17.57% | 16.25% | 13.20% | 11.00% | 15.53% |
Cost of Revenue | 2,013 | 1,980 | 1,702 | 1,482 | 1,311 | 1,193 |
Gross Profit | 315.03 | 313.73 | 249.73 | 196.01 | 172.13 | 142.34 |
Selling, General & Admin | 187.68 | 182.59 | 149.07 | 115.57 | 100.73 | 97.75 |
Other Operating Expenses | 6.89 | 6.38 | 3.69 | 3.61 | 1.47 | -0.29 |
Operating Expenses | 239.81 | 233.33 | 189.68 | 151.29 | 132.26 | 126.29 |
Operating Income | 75.21 | 80.4 | 60.05 | 44.71 | 39.87 | 16.05 |
Interest Expense | -12.66 | -12.44 | -9.76 | -8.42 | -5.18 | -5.36 |
Interest & Investment Income | 0.96 | 1.04 | 1.1 | 0.47 | 0.71 | 2.11 |
Earnings From Equity Investments | 0.01 | -0.06 | -0.01 | - | - | - |
Currency Exchange Gain (Loss) | -1.69 | 1.24 | -4.47 | -0.13 | -0.11 | -0.16 |
Other Non Operating Income (Expenses) | -0.74 | -0.67 | -0.71 | -2.63 | -1.75 | -0.97 |
EBT Excluding Unusual Items | 61.09 | 69.52 | 46.22 | 34 | 33.55 | 11.66 |
Merger & Restructuring Charges | - | - | -0.12 | - | - | - |
Impairment of Goodwill | - | - | - | - | -13.33 | - |
Gain (Loss) on Sale of Assets | 0.6 | 0.56 | 0.57 | 0.21 | 0.46 | 0.3 |
Asset Writedown | -0.08 | -0.1 | - | - | -8.28 | -2.64 |
Other Unusual Items | - | - | 0.34 | - | - | 0.12 |
Pretax Income | 61.6 | 69.98 | 47.01 | 34.21 | 12.39 | 9.44 |
Income Tax Expense | 10.9 | 11.59 | 7.23 | 5 | 3.31 | 1.39 |
Earnings From Continuing Operations | 50.7 | 58.39 | 39.78 | 29.21 | 9.08 | 8.05 |
Minority Interest in Earnings | 0.12 | -0.32 | 0.49 | - | - | - |
Net Income | 50.83 | 58.07 | 40.27 | 29.21 | 9.08 | 8.05 |
Net Income to Common | 50.83 | 58.07 | 40.27 | 29.21 | 9.08 | 8.05 |
Net Income Growth | 0.50% | 44.21% | 37.87% | 221.67% | 12.80% | -29.85% |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Change (YoY) | -0.67% | -0.67% | -0.13% | - | - | - |
EPS (Basic) | 1.50 | 1.71 | 1.18 | 0.85 | 0.26 | 0.23 |
EPS (Diluted) | 1.50 | 1.71 | 1.18 | 0.85 | 0.26 | 0.23 |
EPS Growth | 1.18% | 45.18% | 38.05% | 221.67% | 12.80% | -29.85% |
Free Cash Flow | 12.98 | -21.05 | 54.64 | 37.63 | 12.84 | -180.39 |
Free Cash Flow Per Share | 0.38 | -0.62 | 1.60 | 1.10 | 0.38 | -5.26 |
Gross Margin | 13.54% | 13.68% | 12.80% | 11.68% | 11.61% | 10.66% |
Operating Margin | 3.23% | 3.50% | 3.08% | 2.66% | 2.69% | 1.20% |
Profit Margin | 2.18% | 2.53% | 2.06% | 1.74% | 0.61% | 0.60% |
Free Cash Flow Margin | 0.56% | -0.92% | 2.80% | 2.24% | 0.87% | -13.50% |
EBITDA | 86.59 | 97.77 | 74.3 | 57.49 | 67.21 | 28.08 |
EBITDA Margin | 3.72% | 4.26% | 3.81% | 3.43% | 4.53% | 2.10% |
D&A For EBITDA | 11.37 | 17.37 | 14.24 | 12.78 | 27.34 | 12.03 |
EBIT | 75.21 | 80.4 | 60.05 | 44.71 | 39.87 | 16.05 |
EBIT Margin | 3.23% | 3.50% | 3.08% | 2.66% | 2.69% | 1.20% |
Effective Tax Rate | 17.69% | 16.56% | 15.37% | 14.62% | 26.73% | 14.70% |
Advertising Expenses | - | 10.82 | 11.21 | 6.55 | 4.14 | 3.46 |